I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Camrelizumab combined with apatinib and nanoparticle albumi..:
Xingxiang Pu
;
Gen Lin
;
Maoliang Xiao
...
http://www.sciencedirect.com/science/article/pii/S2589537023005801. , 2024
Link:
https://doi.org/10.1016/j.eclinm.2023.102403
RT Journal T1 <Title>Camrelizumab combined with apatinib and nanoparticle albumin-bound paclitaxel in lung adenocarcinoma (CAPAP-lung): a single-arm phase II studyResearch in context</Title> UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:bd7cf6b86de74344ba804c838845cf40&Exemplar=1&LAN=DE A1 Xingxiang Pu A1 Gen Lin A1 Maoliang Xiao A1 Jie Lin A1 Qianzhi Wang A1 Yi Kong A1 Xuejun Yan A1 Fang Xu A1 Yan Xu A1 Jia Li A1 Kang Li A1 Bolin Chen A1 Xiaoping Wen A1 Yali Tan A1 Fengzhuo Cheng A1 Kangle Zhu A1 Na Li A1 Lin Wu PB Elsevier YR 2024 K1 Advanced non-small cell lung cancer (NSCLC) K1 Platinum-free chemotherapy K1 Immunotherapy K1 Antiangiogenic therapy K1 Efficacy K1 Safety K1 Medicine (General) K1 R5-920 JF http://www.sciencedirect.com/science/article/pii/S2589537023005801 LK http://dx.doi.org/https://doi.org/10.1016/j.eclinm.2023.102403 DO https://doi.org/10.1016/j.eclinm.2023.102403 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)
